<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04005092</url>
  </required_header>
  <id_info>
    <org_study_id>NMRR-17-1839-36966</org_study_id>
    <nct_id>NCT04005092</nct_id>
  </id_info>
  <brief_title>Helmet CPAP Versus HFNC in Acute Cardiogenic Pulmonary Edema</brief_title>
  <acronym>HCPAPvsHFNC</acronym>
  <official_title>Helmet Continuous Positive Airway Pressure Versus High Flow Nasal Cannula Oxygen in Acute Cardiogenic Pulmonary Oedema: A Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Raja Permaisuri Bainun</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Raja Permaisuri Bainun</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study objectively held to compare the physiological outcomes in the non-invasive (NIV)
      treatment of Acute Cardiogenic Pulmonary Oedema (ACPE) patients in the Emergency Department
      (ED) delivered by Helmet CPAP (hCPAP) and HFNC.Patients will be randomized to receive either
      hCPAP or HFNC.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Non-invasive ventilation(NIV) has different types of interfaces that had been used in acute
      hypoxaemic and hypercapnic respiratory failure. The appropriate interface is necessary to
      provide comfort and lead to the success of NIV.

      Helmet continuous positive airway pressure (hCPAP) is an NIV interface that allows the
      provision of high airway pressures with a minimal leak.

      HFNC which delivers heated humidified high flow oxygen provides a good alternative to the
      conventional NIV in terms of comfort
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Actual">September 30, 2018</completion_date>
  <primary_completion_date type="Actual">August 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Respiratory Rate</measure>
    <time_frame>1 hour</time_frame>
    <description>Respiratory rate reduction post intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>1 hour</time_frame>
    <description>Heart rate reduction post intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Partial Pressure Of Arterial Oxygen Level</measure>
    <time_frame>1 hour</time_frame>
    <description>Partial arterial oxygen level post intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ratio Of Partial Pressure Arterial Oxygen And Fraction Of Oxygen</measure>
    <time_frame>1 hour</time_frame>
    <description>Partial arterial oxygen/fraction of oxygen ratio improvement post intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspnoea Scale</measure>
    <time_frame>1 hour</time_frame>
    <description>Dyspnoea scale improvement post intervention.Dyspnea scale measured using an unmarked 10cm VAS card that had mark with &quot;I can breathe normally&quot;, at one end correspond to patients' normal baseline breathing which score &quot;0&quot; and on the other end &quot;I can't breathe at all&quot;, which score &quot;10&quot; represent the worst difficulty perceived by patients.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate,Acidosis (pH), Consciousness (GCS), Oxygenation (PF ratio) And Respiratory Rate(HACOR) Score</measure>
    <time_frame>1 hour</time_frame>
    <description>Heart rate,Acidosis (pH), Consciousness (GCS), Oxygenation (PF ratio) and Respiratory rate(HACOR) Score improvement post intervention.HACOR is an acronym for heart rate, acidosis (pH), consciousness (GCS), oxygenation (PF ratio) and respiratory rate in which each parameter is an independent predictor for NIV failure. HACOR score is out of 25 with differential weighting of each parameter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate Of Intubation</measure>
    <time_frame>1 hour</time_frame>
    <description>Intubation rate post intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>28-Days Mortality In Acute Cardiogenic Pulmonary Edema</measure>
    <time_frame>28 days</time_frame>
    <description>Mortality due to Acute Cardiogenic Pulmonary Edema</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">188</enrollment>
  <condition>Cardiogenic Pulmonary Edema</condition>
  <arm_group>
    <arm_group_label>Helmet Continuous Positive Airway Pressure(hCPAP)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Helmet CPAP produce a better physiological outcomes after 1-hour intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Flow Nasal Cannula(HFNC)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>HFNC produce a better physiological outcomes after 1-hour intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>hCPAP versus HFNC</intervention_name>
    <description>The patient presented with Acute Cardiogenic Pulmonary Edema will be randomized into either helmet CPAP or HFNC.</description>
    <arm_group_label>Helmet Continuous Positive Airway Pressure(hCPAP)</arm_group_label>
    <arm_group_label>High Flow Nasal Cannula(HFNC)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        All patients aged more than 18 years old presented with acute cardiogenic pulmonary oedema.

        Exclusion Criteria:

          1. Age less than 18 years old

          2. Low GCS (less than 8), altered mental status

          3. Hemodynamic instability, impending cardiopulmonary arrest

          4. Use of vasopressors, inotropes

          5. Exacerbation of asthma or chronic respiratory failure

          6. Urgent need for endotracheal intubation

          7. Absence of airway protective gag reflex

          8. Elevated intracranial pressure

          9. Tracheostomy

         10. Pregnant

         11. Upper airway obstruction

         12. Injuries or surgery to head and neck less than 6 months upon presentation

         13. Claustrophobia

         14. Blind or poor vision

         15. Medico-legal related cases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ADI OSMAN</last_name>
    <role>Principal Investigator</role>
    <affiliation>EMERGENCY DEPARTMENT, HOSPITAL RAJA PERMAISURI BAINUN, IPOH, PERAK, MALAYSIA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Emergency Department, Hospital Raja Permaisuri Bainun</name>
      <address>
        <city>Ipoh</city>
        <state>Perak</state>
        <zip>30450</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Malaysia</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>June 27, 2019</study_first_submitted>
  <study_first_submitted_qc>July 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2019</study_first_posted>
  <last_update_submitted>July 1, 2019</last_update_submitted>
  <last_update_submitted_qc>July 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Raja Permaisuri Bainun</investigator_affiliation>
    <investigator_full_name>Dr. Adi Bin Osman</investigator_full_name>
    <investigator_title>EMERGENCY MEDICINE CONSULTANT</investigator_title>
  </responsible_party>
  <keyword>non invasive ventilation</keyword>
  <keyword>pulmonary edema</keyword>
  <keyword>high flow nasal cannula</keyword>
  <keyword>helmet CPAP</keyword>
  <keyword>respiratory failure</keyword>
  <keyword>hyperaemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Edema</mesh_term>
    <mesh_term>Edema</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

